Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | ¥12.49B | ¥11.24B | ¥8.44B | ¥6.73B | ¥4.66B | ¥2.58B | ¥2.47B |
| Research & development | ¥874.4M | ¥880.0M | ¥946.6M | ¥914.2M | ¥729.7M | ¥413.4M | ¥396.7M |
| Operating income | ¥4.15B | ¥2.47B | ¥997.4M | −¥162.0M | −¥3.80B | −¥3.61B | −¥1.02B |
| EBITDAderived | ¥4.25B | ¥2.55B | ¥1.07B | −¥73.7M | −¥3.73B | −¥3.55B | −¥949.9M |
| Net income | ¥4.46B | ¥3.12B | ¥2.23B | ¥411.9M | −¥3.65B | −¥3.47B | −¥1.52B |
| Basic EPSper diluted share | CN¥0.21 | CN¥0.15 | CN¥0.10 | CN¥0.02 | -CN¥0.31 | -CN¥1.05 | -CN¥0.46 |
| Diluted EPSper diluted share | CN¥0.21 | CN¥0.15 | CN¥0.10 | CN¥0.02 | -CN¥0.31 | -CN¥1.05 | -CN¥0.46 |